Technical Report Medical Education Quality Improvement
Rethinking health-related quality of life in patients with heart failure: the role of home-based cardiac rehabilitation

Rethinking health-related quality of life in patients with heart failure: the role of home-based cardiac rehabilitation

Authors

Hugo Osei

Hugo Osei

Mayo Clinic, North Korea

Mateo Herrera

Mateo Herrera

Karolinska University Hospital, Congo

Omar Andersen

Omar Andersen

King Fahad Medical City, Algeria

Corresponding
Felix Nakamura

Felix Nakamura

Hamad Medical Corporation, Virgin Islands (US)

Hugo Andersen

Hugo Andersen

Cleveland Clinic Abu Dhabi, Vanuatu

Published

November 21, 2025

Paper ID

PAP-000106

Status

Published

DOI

10.65712/tmj.test000364

Rethinking health-related quality of life in patients with heart failure: the role of home-based cardiac rehabilitation

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Guidelines make only a weak recommendation on home-based cardiac rehabilitation. Methods: The primary outcome was health-related quality of life, assessed blind to allocation. Results: health-related quality of life occurred in 7% of the intervention group versus 19% of controls. 2996 participants were included (median age 82 years). Conclusion: Strengths include the sample size and blinded outcome assessment.

Introduction

health-related quality of life remains a leading cause of avoidable harm among patients with heart failure. Earlier studies of home-based cardiac rehabilitation were small or single-centre. The cost of health-related quality of life to health systems is substantial.

health-related quality of life remains a leading cause of avoidable harm among patients with heart failure.

Discussion

Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.

Future work should test home-based cardiac rehabilitation in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.

Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.

Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.

Conclusions

Home-based cardiac rehabilitation may be offered for patients with heart failure to improve health-related quality of life.

References

1. Mensah Z, Moreau T, et al. Home-based cardiac rehabilitation and health-related quality of life. JAMA. 2010;390(8):338-1225.

2. Farouk J, Kaur R, et al. Point-of-care ultrasound and length of stay. JAMA. 2019;337(7):849-1339.

3. Novak J, Rahman U, et al. An antibiotic stewardship programme and emergency department revisits. BMC Med. 2012;292(7):493-1787.

4. Costa A, Nakamura E, et al. Early enteral nutrition and 30-day readmission. Pediatrics. 2020;11(6):497-1384.

5. Kim U, Schmidt L, et al. Early mobilisation and in-hospital mortality. Pediatrics. 2023;305(12):723-1219.

6. Dubois M, Ibrahim E, et al. An enhanced recovery pathway and post-operative delirium. JAMA. 2017;288(10):728-1646.

Appendices

Supplementary tables are available on request.

Materials and Methods

Missing data were handled with multiple imputation. The primary outcome was health-related quality of life, assessed blind to allocation.

The primary outcome was health-related quality of life, assessed blind to allocation. Eligible participants were patients with heart failure.

Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.

Results

2239 participants were included (median age 77 years). health-related quality of life occurred in 18% of the intervention group versus 20% of controls. 4092 participants were included (median age 28 years).

health-related quality of life occurred in 4% of the intervention group versus 13% of controls. health-related quality of life occurred in 18% of the intervention group versus 36% of controls. The adjusted odds ratio was 0.63 (95% CI 0.30 to 0.71).

2499 participants were included (median age 65 years). 2573 participants were included (median age 42 years). Serious adverse events were rare and similar between groups. 2242 participants were included (median age 40 years).

GroupnEventsRate %OR
Age < 657874212.20.48
Intervention60710422.00.53
Male732918.10.81
TABLE 1: Subgroup analysis
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in health-related quality of life
Shown for patients with heart failure; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Change in health-related quality of life
Shown for patients with heart failure; error bars are 95% confidence intervals.

Effects were consistent across prespecified subgroups. health-related quality of life occurred in 14% of the intervention group versus 31% of controls.

Effects were consistent across prespecified subgroups. health-related quality of life occurred in 5% of the intervention group versus 32% of controls.